0001437749-24-022360.txt : 20240709
0001437749-24-022360.hdr.sgml : 20240709
20240709092042
ACCESSION NUMBER: 0001437749-24-022360
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240703
FILED AS OF DATE: 20240709
DATE AS OF CHANGE: 20240709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zanganeh Mahkam
CENTRAL INDEX KEY: 0001507650
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37744
FILM NUMBER: 241106467
MAIL ADDRESS:
STREET 1: 51 ADAM WAY
CITY: ATHERTON
STATE: CA
ZIP: 94027
FORMER NAME:
FORMER CONFORMED NAME: Zanganeh Maky
DATE OF NAME CHANGE: 20101210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PULSE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001625101
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 465696597
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-906-4600
MAIL ADDRESS:
STREET 1: 3957 POINT EDEN WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: Pulse Biosciences, Inc.
DATE OF NAME CHANGE: 20151210
FORMER COMPANY:
FORMER CONFORMED NAME: Electroblate, Inc.
DATE OF NAME CHANGE: 20141113
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-07-03
0001625101
PULSE BIOSCIENCES, INC.
PLSE
0001507650
Zanganeh Mahkam
3957 POINT EDEN WAY
HAYWARD
CA
94545
1
0
Common Stock
2024-07-03
4
X
0
60242
A
665153
D
Common Stock
27000
I
Immediate Family Member 1
Common Stock
14000
I
Immediate Family Member 2
Common Stock
107074
I
Immediate Family Member 3
Warrant (right to buy)
11
2024-07-03
4
P
0
30121
A
2024-07-03
2029-07-03
Common Stock
30121
30121
D
Warrant (right to buy)
11
2024-07-03
4
P
0
30121
A
2024-07-03
2029-07-03
Common Stock
30121
30121
D
The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.
Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.
/s/ Kenneth B. Stratton, as Attorney-in-Fact
2024-07-09